MgrB Inactivation Is Responsible for Acquired Resistance to Colistin in Enterobacter hormaechei subsp. steigerwaltii

Autor: Slim Tounsi, Corinne Arpin, Dominique Bégu, Amel Mhaya

Publikováno v: Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2020, 64 (6), pp.e00128-20. ⟨10.1128/AAC.00128-20⟩

International audience; Multidrug-resistant strains belonging to the Enterobacter cloacae complex (ECC) group, and especially those belonging to clusters C-III, C-IV, and C-VIII, have increasingly emerged as a leading cause of health care-associated

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cad641324ad71b81e950790f408d6b6
https://hal-cnrs.archives-ouvertes.fr/hal-02980500/document

The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae

Autor: Melda Ozdamar, Aurélie Jayol, Laurent Poirel, Maria Virginia Villegas, Salih Turkoglu, Séverine Bontron, Patrice Nordmann

WOS: 000350210800010 PubMed ID: 25190723 Objectives: Alterations in the PhoPQ two-component regulatory system may be associated with colistin resistance in Klebsiella pneumoniae. MgrB is a small transmembrane protein produced upon activation of the P

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58280538730365b70bb6713c06a81f22
https://hdl.handle.net/20.500.12511/2949

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.